Insulet

About:

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System.

Website: https://www.omnipod.com

Twitter/X: myomnipod

Top Investors: Deerfield, Versant Ventures, Alta Partners, SV Health Investors, Piper Sandler

Description:

Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes primarily in the United States. The company offers OmniPod Insulin Management System (OmniPod System), an insulin infusion system that provides a pain-free automated cannula insertion. The OmniPod System consists of OmniPod disposable insulin infusion device and handheld wireless personal diabetes manager; and provides people with a diabetes management solution that offers lifestyle and other benefits. The company sells the OmniPod System directly to patients through referrals from healthcare professionals and through patient leads. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.

Total Funding Amount:

$130M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Bedford, Massachusetts, United States

Founded Date:

2000-01-01

Contact Email:

international(AT)insulet.com

Founders:

Number of Employees:

501-1000

Last Funding Date:

2009-03-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai